PLEASE CLICK ON THE TITLE OF THE PRESENTATION TO SEE IT
Health-related quality of life after Hyperthermic intraperitoneal Chemotherapy (HIPEC) for stage III ovarian cance : results of the phase III OVHIPEC study
A phase I trial assessing the feasibility of debulking surgery followed by cisplatin-based hyperthermic Intraperitoneal chemotherapy and intraperitoneal bi-monthly nivolumab in advanced ovarian carcinoma. the ICONIC study
A. Gonzalez Gil
Morbidity and mortality after a first cytoreductivewith or without HIPEC in ovarian cancer IIIC-IV. Preliminary results of the Prospective and Randomized clinical trial.
Time to adjuvant chemotherapy and impact on survival in advanced ovarian malignancies: Indian Society of Peritoneal Surface Malignancy (ISPSM) collabortive group study
WJ. Van Driel
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) associatd with systemic chemotherapy with VEGF-A, evalutation of safety and feasibility